Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Indications for Minimally Invasive Procedures to Treat Diseased Brain Vessels

By HospiMedica International staff writers
Posted on 20 Apr 2009
The American Heart Association (AHA; Dallas, TX, USA) and the American Stroke Association (ASA; Dallas, TX, USA) have published a joint statement providing recommendations for minimally invasive procedures to treat brain blood vessel diseases based on best available evidence.

The new statement addresses the use of stenting, coil embolization, in-artery delivery of clot busting drugs, and mechanical clot-removing devices for the treatment of brain aneurysms, narrowed brain arteries, acute ischemic stroke, and arteriovenous malformations. More...


A summary of the recommendations includes: (1) Ruptured aneurysms: Endovascular coil occlusion of the aneurysm is appropriate if the aneurysm is deemed treatable by either endovascular coiling or surgical clipping. (2) Unruptured aneurysms: The investigators deem it "reasonable" to consider endovascular occlusion for unruptured aneurysms if the aneurysm is thought to require intervention over conservative management and is amenable to endovascular treatment according to an endovascular specialist. (3) Intracranial stenosis: For symptomatic atherosclerotic stenosis greater than 70% and failing medical therapy, endovascular revascularization with angioplasty or stenting might be reasonable. (4) Acute ischemic stroke: For patients with a major stroke syndrome lasting six hours or less, and who are either ineligible for or who have failed intravenous thrombolysis, it is reasonable to consider intra-arterial thrombolysis in selected patients. For patients with a major stroke syndrome lasting eight or more hours, it may be reasonable to use mechanical disruption to restore blood flow in selected patients. (5) Cerebral arteriovenous malformation (AVM): For patients with hemorrhage referable to an AVM, endovascular treatment in combination with other therapies, such as surgery or radiosurgery, should be considered as a preoperative adjunct or palliative treatment to prevent recurrent hemorrhage. For those with neurologic symptoms or hemorrhage referable to a dural arteriovenous fistula, endovascular treatment alone might be curative or might be used in combination with other therapies, such as surgery or radiosurgery, as palliative treatment to prevent stroke or hemorrhage.

The new statement, titled "Indications for the performance of intracranial endovascular neurointerventional procedures," was published online on April 6, 2009, in Circulation, the journal of the American Heart Association.

Related Links:
American Heart Association
American Stroke Association


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.